Dr. Michelle L. Hermiston
Claim this profileUCSF School of Medicine
Studies Leukemia
Studies Acute Lymphoblastic Leukemia
9 reported clinical trials
25 drugs studied
Area of expertise
1Leukemia
CD123 positive
Stage III
Stage IV
2Acute Lymphoblastic Leukemia
CD123 positive
Affiliated Hospitals
Clinical Trials Michelle L. Hermiston is currently running
DAY101
for Langerhans Cell Histiocytosis
This trial tests the safety and effectiveness of tovorafenib (DAY101) in children and young adults with Langerhans cell histiocytosis that is worsening, has returned, or does not respond to other treatments. Tovorafenib is taken orally and works by blocking enzymes needed for cancer cell growth. The study aims to find the best dose and observe the response and side effects over time.
Recruiting1 award Phase 228 criteria
Caloric Restriction + Activity
for Acute Lymphoblastic Leukemia
This trial tests if a personalized diet and exercise plan can help older children, adolescents, and young adults with high-risk B-cell Acute Lymphoblastic Leukemia respond better to chemotherapy. The plan aims to reduce body fat, which is linked to treatment resistance, and limit fat gain during chemotherapy.
Recruiting1 award Phase 2
More about Michelle L. Hermiston
Clinical Trial Related8 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Michelle L. Hermiston has experience with
- Brentuximab Vedotin
- Etoposide
- Dexamethasone
- Nivolumab
- Ruxolitinib
- Fludarabine
Breakdown of trials Michelle L. Hermiston has run
Leukemia
Acute Lymphoblastic Leukemia
Hodgkin's Lymphoma
Relapse
Acute Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michelle L. Hermiston specialize in?
Michelle L. Hermiston focuses on Leukemia and Acute Lymphoblastic Leukemia. In particular, much of their work with Leukemia has involved CD123 positive patients, or patients who are Stage III.
Is Michelle L. Hermiston currently recruiting for clinical trials?
Yes, Michelle L. Hermiston is currently recruiting for 4 clinical trials in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Michelle L. Hermiston has studied deeply?
Yes, Michelle L. Hermiston has studied treatments such as Brentuximab Vedotin, Etoposide, Dexamethasone.
What is the best way to schedule an appointment with Michelle L. Hermiston?
Apply for one of the trials that Michelle L. Hermiston is conducting.
What is the office address of Michelle L. Hermiston?
The office of Michelle L. Hermiston is located at: UCSF School of Medicine, San Francisco, California 94158 United States. This is the address for their practice at the UCSF School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.